Antiangiogenic characteristics of astrocytes from optic nerve heads with primary open-angle glaucoma

Archives of Ophthalmology

Volumn 126, Issue 5, 2008, Pages 679-685

  Rudzinski, Marcelo N ^a   Chen, Lin ^a   Hernandez, M Rosario ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 18; ENDOSTATIN; GLYCOPROTEIN; PLATELET DERIVED GROWTH FACTOR A; PROTEIN ADAMTSL 3; VASCULOTROPIN A; VASCULOTROPIN C;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIBODY LABELING; ARTICLE; ASTROCYTE; CELL CULTURE; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GLAUCOMA, OPEN-ANGLE; HUMANS; OPTIC DISK; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS;

EID: 43549097367     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.5.679     Document Type: Article

References (49)

1. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol. 1983;118(2):166-191.
2. Quigley HA. New paradigms in the mechanisms and management of glaucoma. Eye. 2005;19(12):1241-1248.
3. Weinreb RN. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711-1720.
4. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39-57.
5. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res. 2000;19(3):297-321.
6. Varela HJ. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J Glaucoma. 1997;6(5):303-313.
7. Liu B, Johns TG, Neufeld AH. Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury. J Neurosci. 2006;26(28):7532-7540.
8. Pena JD, Vidal I, Dorr DA, Rasky A, Hernandez MR. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp Eye Res. 1998;67(5):517-524.
9. Pena JD, Ricard CS, Hernandez MR. Enhanced tenascin expression associated with reactive astrocytes in human optic nerve heads with primary open angle glaucoma. Exp Eye Res. 1999;68(1):29-40.
10. Hernandez MR, Selvidge JA, Salvador-Silva M, Yang P. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia. 2000;32(2):122-136.
11. Hernandez MR, Yang P, Salvador-Silva M, Ricard CS, Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia. 2002;38(1):45-64.
12. Liu B, Neufeld AH. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia. 2000;30(2):178-186.
13. Liu B, Neufeld AH. Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch Ophthalmol. 2001;119(2):240-245.
14. Risau W. Mechanisms of angiogenesis. Nature. 1997;386(6626):671- 674.
15. Noma H, Yamashita H, Kitano S, Mishima HK, Hori S. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin. Arch Ophthalmol. 2002;120(8):1075-1080.
16. Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997;151(1):13-23.
17. Shima DT, Ferrara N, Yeo KT, et al. Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol Med. 1995;1(2):182-193.
18. Sudhakar A, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5beta;1 integrins. Proc Natl Acad Sci U S A. 2003;100(8):4766-4767.
19. Blezinger P, Gondo M, Quezada A, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol. 1999;17(4):343-348.
20. 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem. 2000;275(31):23745-23750.
21. Heljasvaara R, Nyberg P, Luostarinen J, et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res. 2005;307(2):292-304.
22. Määttä M, Pihlajaniemi T, Uusitalo M. Collagen XVIII/endostatin shows a ubiquitous distribution in human ocular tissues and endostatin-containing fragments accumulate in ocular fluid samples. Graefes Arch Clin Exp Ophthalmol. 2007;245(1):74-81.
23. Hurskainen M, Hagg PO, Fruttiger M, Sormunen R, Ilves M, Pihlajaniemi T. Abnormal maturation of the retinal vasculature in type XVIII collagen/endostatin deficient mice and changes in retinal glial cells due to lack of collagen types XV and XVIII. FASEB J. 2005;19(11):1564-1566.
24. Porter S, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J. 2005;386(pt 1):15-27.
25. Margolis R, Singh RP, Kaiser PK. Branch retinal vein occlusion: clinical findings, natural history, and management. Compr Ophthalmol Update. 2006;7(6):265-276.
26. Tezel G, Wax MB. Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head. Arch Ophthalmol. 2004;122(9):1348-1356.
27. Wang L, Fortune B, Cull G, Dong J, Cioffi GA. Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. Arch Ophthalmol. 2006; 124(5):717-724.
28. Kobayashi S, Pena JD, Hernandez MR. Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia. 1997;20(3):262-273.
29. Yang P. Purification of astrocytes from adult human optic nerve heads by immunopanning. Brain Res Brain Res Protoc. 2003;12(2):67-76.
30. Agapova OA, Salvador-Silva M, Hernandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia. 2001;33(3):205-216.
31. Salvador-Silva M, Agapova OA, Yang P, Hernandez MR. Expression of small heat shock proteins and intermediate filaments in the human optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. J Neurosci Res. 2001;66(1):59-73.
32. Garcia CM, Massingham LJ, D'Amore PA. Endothelial cell-astrocyte interactions and TGFβ are required for induction of blood-neural barrier properties. Brain Res Dev Brain Res. 2004;152(1):25-38.
33. Tsuneki H, Kobayashi S, Sekizaki N, et al. Antiangiogenic activity of β-eudesmol in vitro and in vivo. Eur J Pharmacol. 2005;512(2-3):105-115.
34. Miternique-Grosse A, Siegel L, Neuville A, Weltin D, Stephan D. Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats. J Hypertens. 2006;24(11):2207-2213.
35. Lam HW, Lin HC, Lao SC, et al. The angiogenic effects of Angelica sinensis extract on HUVEC in vitro and zebrafish in vivo. J Cell Biochem. 2008;103(1):195-211.
36. Becker B, Bresnick G, Chevrette L, Kolker AE, Oaks MC, Cibis A. Intraocular pressure and its response to topical corticosteroids in diabetes. Arch Ophthalmol. 1966;76(4):477-483.
37. Neetens A. Intraocular pressure and diabetic retinopathy. Bibl Anat. 1977;16(16, pt 2):437-441.
38. Gottanka J, Kuhlmann A, Scholz M, Johnson DH, Lutjen , Drecoll E. Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2005;46(11):4170-4181.
39. Vinores SA, Luna JD, Chen YS, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol. 1997;12(1):99-109.
40. Mori K, Ando A, Dyer G, et al. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci. 2002;43(6):2001-2006.
41. Fruttiger M. Development of the retinal vasculature. Angiogenesis. 2007;10(2):77-88.
42. West H, Fruttiger M. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development. 2005;132(8):1855-1862.
43. Yang P, Parker A, Shannon W, et al. DNA microarray analysis of gene expression in human optic nerve head astrocytes in response to hydrostatic pressure. Physiol Genomics. 2004;17(2):157-169.
44. Joukov V, Pajusola K, Kaipinen A, et al. A novel vascular endothelial growth factor, VEGFC, is a ligand for the flt4 (VEGF-R3) and KDR (VEGF-R2) receptor tyrosine kinases. EMBO J. 1996;15(2):290-298.
45. Dong J, Tejada M, Peale F, et al. VEGF-null cells require PDGFR α signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J. 2004;23(14):2800-2810.
46. Shikada Y, Koga T, Onimaru M, et al. Platelet-derived growth factor-AA is an essential and autocrine regulator of vascular endothelial growth factor expression in non-small cell lung carcinomas. Cancer Res. 2005;65(16):7241-7248.
47. Rege TA, Fears CY, Gladson CL. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy. Neuro Oncol. 2005;7(2):106-121.
48. Campbell M, McEvoy A, Gardiner TA, Stitt AW, Brankin B. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function. Curr Eye Res. 2006;31(12):1033-1045.
49. Nambu H, Oshima Y, Hackett SF, et al. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther. 2004;11(10):865-873.